WSJ News Exclusive | Blackstone Invests $2 Billion in Alnylam Pharmaceuticals

  • 📰 WSJ
  • ⏱ Reading Time:
  • 18 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 63%

Loans Loans Headlines News

Loans Loans Latest News,Loans Loans Headlines

Blackstone is investing $2 billion in Alnylam Pharmaceuticals, giving the biotech firm the cash it needs to bring more drugs to market

Blackstone Group Inc. is investing $2 billion in Alnylam Pharmaceuticals Inc. through a combination of equity and debt, giving the biotech company the cash it needs to bring more of its products to market.

The biggest piece of the deal, which the companies expect to announce later Monday, consists of a $1 billion investment led by Blackstone Life Sciences to purchase up to 10% of the future total royalties of inclisiran, a drug to treat high cholesterol. The life-sciences unit will also invest up to $150 million in the development...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Wonderful news!

Re-open our country. Pandemics come and go. IN LIFE, WE RISK. We risk with cancer, suicide, auto-immune diseases, terrorism, war, accidents, murder, the comm flu, etc. Heck, we even RISK in the stock market. In life we risk. Americans are NOT DESIGNED to be locked up! NoFear

9-42d3-9aac-73c24e123777The crisis is inherently political because it was caused in part by incompetent, malicious, and corrupt politicians. To ignore the political dimension of the coronavirus pandemic is an excellent way to ensure it happens again.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 98. in LOANS

Loans Loans Latest News, Loans Loans Headlines